Keyword Analysis & Research: tak1 mw

cellsignal.com

https://www.cellsignal.com/products/primary-antibodies/tak1-antibody/4505

WebPolyclonal Antibody for studying TAK1. Cited in 172 publications. Validated for Western Blotting. Highly specific and rigorously validated in-house, TAK1 Antibody (CST #4505) … Category: Primary Antibodies

Category: Primary Antibodies

DA: 10 PA: 78 MOZ Rank: 5

nature.com

https://www.nature.com/articles/cdd2014123

WebAug 22, 2014 · The therapeutic potential of targeting regulated non-apoptotic cell death. Article 07 August 2023. Facts. TAK1 is activated by numerous exogenous and … Author: S R Mihaly, J Ninomiya-Tsuji, S Morioka, S Morioka Publish Year: 2014

Author: S R Mihaly, J Ninomiya-Tsuji, S Morioka, S Morioka

Publish Year: 2014

DA: 94 PA: 83 MOZ Rank: 89

nature.com

https://www.nature.com/articles/cdd2014123

DA: 98 PA: 74 MOZ Rank: 26

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536066/

WebSep 2, 2020 · Owing to its role in TNF inflammatory signalling, TAK1 has become a potential therapeutic target for the treatment of inflammatory diseases such as RA. This review … Author: Juliane Totzke, Scott A. Scarneo, Kelly W. Yang, Timothy A. J. Haystead DOI: 10.1098/rsob.200099 Publish Year: 2020 Publication: Open Biol. 2020 Sep; 10(9): 200099.

Author: Juliane Totzke, Scott A. Scarneo, Kelly W. Yang, Timothy A. J. Haystead

DOI: 10.1098/rsob.200099

Publish Year: 2020

Publication: Open Biol. 2020 Sep; 10(9): 200099.

DA: 14 PA: 81 MOZ Rank: 71

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551703/

WebOct 14, 2021 · Abstract. Chronic insult and persistent injury can cause liver inflammation, fibrosis, and carcinogenesis; it can also be associated with metabolic disorders. … Author: Weijun Wang, Wenkang Gao, Qingjing Zhu, Afnan Alasbahi, Ekihiro Seki, Ling Yang DOI: 10.3389/fcell.2021.734749 Publish Year: 2021 Publication: Front Cell Dev Biol. 2021; 9: 734749.

Author: Weijun Wang, Wenkang Gao, Qingjing Zhu, Afnan Alasbahi, Ekihiro Seki, Ling Yang

DOI: 10.3389/fcell.2021.734749

Publish Year: 2021

Publication: Front Cell Dev Biol. 2021; 9: 734749.

DA: 47 PA: 72 MOZ Rank: 20

springer.com

https://link.springer.com/article/10.1007/s10456-021-09787-5

WebMay 10, 2021 · In this review, we summarize recent studies of TAK1 in angiogenesis and discuss the crosstalk between TAK1 and signaling pathways involved in pathological … Author: Linxin Zhu, Suraj Lama, Leilei Tu, Gregory J Dusting, Jiang-Hui Wang, Guei-Sheung Liu, Guei-Sheung L... Publish Year: 2021

Author: Linxin Zhu, Suraj Lama, Leilei Tu, Gregory J Dusting, Jiang-Hui Wang, Guei-Sheung Liu, Guei-Sheung L...

Publish Year: 2021

DA: 10 PA: 15 MOZ Rank: 17

sciencedirect.com

https://www.sciencedirect.com/science/article/pii/S1534580718310359

WebJan 28, 2019 · TAK1 inhibits endothelial cell death induced by TNF-α-TNFR1 signaling • Endothelial TAK1 is essential for protecting blood vessels from intestinal microbes • …

DA: 79 PA: 49 MOZ Rank: 7

nature.com

https://www.nature.com/articles/s41375-018-0066-4

WebFeb 22, 2018 · Detection of phosphorylated TAK1 at T444 and T344 is associated with the presence of lymphoma in a set of 60 primary human samples correlating with NF-κB and …

DA: 25 PA: 87 MOZ Rank: 22

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350196/

WebMay 5, 2021 · TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance - PMC. Journal List. Cell Mol Gastroenterol Hepatol. v.12 (3); 2021. …

DA: 6 PA: 82 MOZ Rank: 21